REFERENCES
- Sankaranarayanan J, Puumala S E. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996–2003: National estimates and associated factors. Clin Ther 2007; 29: 723–741
- American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596–601
- Wells B G, Marken P A, Rickman L A, Brown C S, Hamann G, Grimmig J. Characterizing anticholinergic abuse in community mental health. J Clin Psychopharmacol 1989; 9: 431–435
- Waters B M, Joshi K G. Intravenous quetiapine-cocaine use (“Q-ball”). Am J Psychiatry 2007; 164: 173–174
- Redbook: Pharmacy's fundamental reference, L Murray. Thomson, Montvale, NJ 2007
- Kapur S, Zipursky R, Jones C, Shammi C S, Remington G, Seeman P. A positron emission tomography study of quetiapine in schizophrenia: A preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry 2000; 57: 553–559